Clinical Trial Update: The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating the effects of Acthar on synovial inflammation in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Acthar (repository corticotropin injection)

Snippet

Sponsor: Attune Health Research, Inc. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: UNKNOWN